Literature DB >> 20026116

Neutrophil migration during liver injury is under nucleotide-binding oligomerization domain 1 control.

Sébastien Dharancy1, Mathilde Body-Malapel, Alexandre Louvet, Dominique Berrebi, Emilie Gantier, Philippe Gosset, Jérôme Viala, Antoine Hollebecque, Christophe Moreno, Dana J Philpott, Stephen E Girardin, Philippe J Sansonetti, Pierre Desreumaux, Philippe Mathurin, Laurent Dubuquoy.   

Abstract

BACKGROUND & AIMS: A more complete understanding of the mechanisms involved in pathogen-associated molecular pattern signaling is crucial in the setting of liver injury. In intestinal diseases, nucleotide-binding oligomerization domain 1 (NOD1), a receptor for bacteria, appears to regulate cross-talk between innate and adaptive immunity, involving polymorphonuclear neutrophils (PMNs). Our aim was to explore the role of NOD1 in PMN-induced liver injury.
METHODS: Nod1(+/+) and Nod1(-/-) mice were challenged with carbon tetrachloride (CCl(4)). Migration and phagocytosis of Nod1(+/+) and Nod1(-/-) PMN were studied in vivo and ex vivo. We evaluated main inflammatory pathways in PMNs by Western blot and CD11b expression using fluorescence-activated cell sorting. Mice were submitted to liver ischemia/reperfusion.
RESULTS: After CCl(4) exposure, livers of Nod1(-/-) mice had more than 50% less PMN infiltration within necrotic areas than those of Nod1(+/+). PMNs isolated from Nod1(-/-) mice displayed a 90% decrease in migration capacity compared with Nod1(+/+) PMNs, whereas FK 565, a potent NOD1 ligand, increased PMN migration. Upon FK 565 stimulation, mitogen-activated protein kinase and nuclear factor kappaB were activated in Nod1(+/+) PMNs, but less so in Nod1(-/-) PMNs. Expression of CD11b on the Nod1(-/-) PMN was decreased compared with Nod1(+/+). The phagocytic capacity of Nod1(-/-) PMNs was decreased by more than 50% compared with Nod1(+/+). In an ischemia/reperfusion model of PMN-induced liver injury, FK 565 increased lesions, whereas Nod1(-/-) mice were protected.
CONCLUSIONS: The identification of NOD1 as a modulator of PMN function and migration in the liver suggests that this receptor may represent a new therapeutic target in PMN-dependent liver diseases. 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20026116     DOI: 10.1053/j.gastro.2009.12.008

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  20 in total

1.  Nod2 and Rip2 contribute to innate immune responses in mouse neutrophils.

Authors:  Yu-Jin Jeong; Min-Jung Kang; Sang-Jin Lee; Chang-Hwan Kim; Jee-Cheon Kim; Tae-Hyoun Kim; Dong-Jae Kim; Donghyun Kim; Gabriel Núñez; Jong-Hwan Park
Journal:  Immunology       Date:  2014-10       Impact factor: 7.397

2.  Effects of polymorphisms in nucleotide-binding oligomerization domains 1 and 2 on biomarkers of the metabolic syndrome and type II diabetes.

Authors:  Cristina Cuda; Alaa Badawi; Mohamed Karmali; Ahmed El-Sohemy
Journal:  Genes Nutr       Date:  2012-02-26       Impact factor: 5.523

3.  Ethanol extract of Portulaca Oleracea L. reduced the carbon tetrachloride induced liver injury in mice involving enhancement of NF-κB activity.

Authors:  Hongguang Shi; Xuefeng Liu; Gusheng Tang; Haiyan Liu; Yinghui Zhang; Bo Zhang; Xuezhi Zhao; Wanyin Wang
Journal:  Am J Transl Res       Date:  2014-11-22       Impact factor: 4.060

Review 4.  New insights into Nod-like receptors (NLRs) in liver diseases.

Authors:  Tao Xu; Yan Du; Xiu-Bin Fang; Hao Chen; Dan-Dan Zhou; Yang Wang; Lei Zhang
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2018-03-10

Review 5.  Therapeutic targeting of NOD1 receptors.

Authors:  L Moreno; T Gatheral
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

Review 6.  Neutrophil-Induced Liver Injury and Interactions Between Neutrophils and Liver Sinusoidal Endothelial Cells.

Authors:  Yang Wang; Yulan Liu
Journal:  Inflammation       Date:  2021-03-01       Impact factor: 4.092

Review 7.  Recognition of Extracellular Bacteria by NLRs and Its Role in the Development of Adaptive Immunity.

Authors:  Jonathan Ferrand; Richard Louis Ferrero
Journal:  Front Immunol       Date:  2013-10-21       Impact factor: 7.561

8.  The CARD8 p.C10X mutation associates with a low anti-glycans antibody response in patients with Crohn's disease.

Authors:  Francis Vasseur; Boualem Sendid; Franck Broly; Corinne Gower-Rousseau; Aurore Sarazin; Annie Standaert-Vitse; Jean-Frederic Colombel; Daniel Poulain; Thierry Jouault
Journal:  BMC Med Genet       Date:  2013-03-18       Impact factor: 2.103

9.  Cyclosporine A impairs nucleotide binding oligomerization domain (Nod1)-mediated innate antibacterial renal defenses in mice and human transplant recipients.

Authors:  Emilie Tourneur; Sanae Ben Mkaddem; Cécilia Chassin; Marcelle Bens; Jean-Michel Goujon; Nicolas Charles; Christophe Pellefigues; Meryem Aloulou; Alexandre Hertig; Renato C Monteiro; Stephen E Girardin; Dana J Philpott; Eric Rondeau; Carole Elbim; Catherine Werts; Alain Vandewalle
Journal:  PLoS Pathog       Date:  2013-01-31       Impact factor: 6.823

Review 10.  Calcineurin/NFAT signaling and innate host defence: a role for NOD1-mediated phagocytic functions.

Authors:  Alain Vandewalle; Emilie Tourneur; Marcelle Bens; Cécilia Chassin; Catherine Werts
Journal:  Cell Commun Signal       Date:  2014-01-30       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.